Clinical trial
Effect of AD128 on Obstructive Sleep Apnea Severity: a Randomized, Placebo-controlled, Double-blind, Cross-over Study
NCT04394143 is registered in ClinicalTrials.gov with Raphael Heinzer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of AD128 on Obstructive Sleep Apnea Severity: a Randomized, Placebo-controlled, Double-blind, Cross-over Study
- Lead sponsor
- Raphael Heinzer
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 20, 2020
- Completion date
- July 19, 2021
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.